360° SearchNetwork Hot Spots Trends Time Series

Aventis Pharma Ltd

Type: Company

Name: Aventis Pharma Ltd

First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports

Aventis Pharmaceuticals Inc. v. Amino Chemicals Ltd. (Fed. Cir. 2013)

By Andrew Williams -- Can the claim term "substantially pure" mean two different things when the specification uses the same term to refer to both an intermediate compound and a final drug product in a specification? The Federal Circuit recently answered ... [Published Patent Docs - Jun 04 2013]

Entities: Sanofi SA, Chemical, Aventis Pharma Ltd, Andrew Williams, Drug Product

First reported Jun 02 2013 - Updated Jun 02 2013 - 1 reports

Pfizer Inc

Paul Reid

has been appointed managing director of Pfizer Healthcare Ireland, the largest investor and employer in the Irish biopharmaceutical sector.Paul will be responsible for the performance of Pfizer's commercial subsidiary in Ireland, which operates six sites ... [Published Irish Independent - Jun 02 2013]

Entities: Paul Reid, Pfizer Inc, Ireland

First reported May 29 2013 - Updated May 29 2013 - 1 reports

Paul Reid appointed MD of Pfizer Healthcare Ireland

Paul Reid has been appointed as managing director of Pfizer Healthcare Ireland, which is responsible for commercialising medicines in the field of inflammation, oncology, vaccines, haemophilia, pain and infective diseases. Reid has over 18 years of pharmaceutical ... [Published Business & Leadership - May 29 2013]

Entities: Paul Reid, Pfizer Inc, Ireland, Health Care, Appointed

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Sanofi SA

Court Rules in Novel False Claims Act Case Where One Pharmaceutical Company Sues Another

By Delia A. Stubbs – The U.S. District Court for the Eastern District of California issued a ruling last week in an unusual, if not unprecedented, case arising from alleged federal False Claims Act (“FCA”) violations where one drug manufacture has sued ... [Published FDA Law Blog - Apr 25 2013]

Entities: Sanofi SA, Amphastar Pharmaceuticals Inc, Enoxaparin, Lovenox

First reported Feb 14 2013 - Updated Feb 15 2013 - 1 reports

Sanofi India launches paracetamol and caffeine combo drug, Combiflam Plus

Sanofi India (previously known as Aventis Pharma), a Rs.1,200 crore plus Mumbai-based multinational pharma major, has launched Combiflam Plus, a targeted, fast and effective solution for headaches, which is also gentle on the stomach.Combiflam Plus is ... [Published PharmaBiz - Feb 14 2013]

Entities: Paracetamol, Sanofi SA, anodyne, India

First reported Jan 02 2013 - Updated Jan 02 2013 - 1 reports

Bombay Stock Exchange

BSE Healthcare Index closes high at 8132.35 with yearly gain of 38.5% on last day of 2012

The Bombay Stock Exchange Healthcare (BSEHC) index of 17 leading pharmaceutical companies outperformed Bombay Stock Exchange Sensitive Index (Sensex) of 30 companies during year 2012 on account of strong fundamentals, higher approvals, product launches, ... [Published PharmaBiz - Jan 02 2013]

Entities: Bombay Stock Exchange, Ranbaxy Laboratories Ltd, Natco Pharma Limited, Aurobindo Pharma Ltd

Quotes

In reversing the lower court's decision, the Federal Circuit highlighted that claims "must be construed in light of the appropriate context in which the claim term is used" (citing Toro Co. v. White Consol. Indus Inc., 199 F 3d 1295 (Fed. Cir. 1999))...

Aventis Pharmaceuticals Inc. v. Amino Chemicals Ltd. (Fed. Cir. 2013) [Published JD Supra - Jun 04 2013]

"The facility adds about 10,600ft³ of stability storage space to SGS' operations in India."

SGS Life Science Services Laboratory Facility, Mumbai, Maharashtra [Published Pharmaceutical Technology - Feb 06 2013]

...For almost three years, Sanofi's scientists worked closely with our team here to develop a device that was "Made in India, for India. AllStar heralds a new era of indigenous device manufacturing for Sanofi India, which we hope to utilize for other devices in future.”"

Sanofi India launches specially designed re-usable insulin pen AllStar [Published PharmaBiz - Oct 09 2012]

...development of business amongst Asian Americans, 1997, (xv) Distinguished Corporate Executive Award by Asian Business League, U S A , 1997, (xvi) "Outstanding CEO, 1989-99 by the Indian Institute of Industrial Engineering, India, 1999, (xvii) Udyog Ratna - Life Time Achievement Award by Wisitex Foundation, India, 2001, and (xviii) Sir M Visvesvaraya Memorial Award by the Federation of Karnataka Chambers of Commerce and Industry, India, 2001; nominated Global Leader for Tomorrow by the World Economic Forum at Davos, Switzerland, 1995; believes that corporations have a responsibility to society and mankind and towards this end, has contributed generously to various charities and foundations in several countries"

Biography for Vijay Mallya [Published Able2Act - Jan 15 2009]

More Content

sort by: Date \| Relevance
Aventis Pharmaceuticals Inc. v. Amino Chemicals... [Published JD Supra - Jun 04 2013]
Aventis Pharmaceuticals Inc. v. Amino Chemicals... [Published Patent Docs - Jun 04 2013]
Paul Reid [Published Irish Independent - Jun 02 2013]
Paul Reid appointed MD of Pfizer Healthcare Ire... [Published Business & Leadership - May 29 2013]
Court Rules in Novel False Claims Act Case Wher... [Published FDA Law Blog - Apr 25 2013]
Sanofi India launches paracetamol and caffeine ... [Published PharmaBiz - Feb 14 2013]
SGS Life Science Services Laboratory Facility, ... [Published Pharmaceutical Technology - Feb 06 2013]
BSE Healthcare Index closes high at 8132.35 wit... [Published PharmaBiz - Jan 02 2013]
Sanofi India launches specially designed re-usa... [Published PharmaBiz - Oct 09 2012]
Biography for Vijay Mallya [Published Able2Act - Oct 03 2007]

Blogs

sort by: Date \| Relevance
Aventis Pharmaceuticals Inc. v. Amino Chemicals... [Published Patent Docs - Jun 04 2013] By Andrew Williams -- Can the claim term "substantially pure" mean two different things when the specification uses the same term to refer to both an intermediate compound and a final drug product in a specification? The Federal Circuit recently answered ...
Court Rules in Novel False Claims Act Case Wher... [Published FDA Law Blog - Apr 25 2013] By Delia A. Stubbs – The U.S. District Court for the Eastern District of California issued a ruling last week in an unusual, if not unprecedented, case arising from alleged federal False Claims Act (“FCA”) violations where one drug manufacture has sued ...